Medical Facilities Corporation
Sembol: DR.TO
TSX
11.25
CADBugünkü piyasa fiyatı
18.3685
F/K Oranı
0.2414
PEG Oranı
281.52M
MRK Kapağı
- 0.04%
DIV Verimi
Medical Facilities Corporation (DR-TO) Finansal Tablolar
Bilanço
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 24.1 | 34.9 | 61 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 62.5 | 64.6 | 67.5 | ||||||||||||||||||||
balance-sheet.row.inventory | 0 | 9 | 9.2 | 10.6 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 7.1 | 10.5 | 9.7 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 102.8 | 119.3 | 148.9 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 120.2 | 124.7 | 132.8 | ||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 120.6 | 120.6 | 136 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 11.3 | 13.1 | 14.4 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 131.9 | 133.7 | 150.4 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | -0.1 | 258.4 | 13.4 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0.1 | 0 | 0.4 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.1 | -258.4 | 1.1 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 252.1 | 258.5 | 298.1 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 354.9 | 377.8 | 447 | ||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 23.2 | 26.4 | 23.9 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 23.5 | 19.9 | 14.8 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 93.3 | 123 | 126.1 | ||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 2.1 | 28.2 | 26.9 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 153.6 | 176.3 | 185.8 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 47.7 | 57.4 | 61.3 | ||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 236.6 | 263.1 | 267.3 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 348.1 | 353.2 | 396 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -262.8 | -275.3 | -263.8 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0.7 | 1.2 | 1.9 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 86 | 79.1 | 134.1 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 354.9 | 377.8 | 447 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 32.3 | 35.6 | 45.6 | ||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 118.3 | 114.7 | 179.7 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||
Total Investments | 0 | -0.1 | 258.4 | 13.4 | ||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 116.8 | 143 | 140.9 | ||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 92.7 | 108 | 79.9 |
Nakit Akış Tablosu
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 44 | 12.3 | 46.5 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 21.5 | 20.8 | 26.8 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 8.3 | 5.2 | 4.4 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -0.5 | -0.7 | 0.3 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -0.5 | -6.2 | -10.4 | ||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 1 | -2.6 | -1.2 | ||||||||||||||||||||
cash-flows.row.inventory | 0 | -0.2 | 1.4 | 0.7 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | -2.5 | 2.5 | -0.5 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 1.2 | -7.5 | -9.3 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -0.2 | 25.6 | 8.1 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -16.1 | -6.7 | -8.4 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 2.4 | 0.9 | -0.3 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -13.7 | -5.8 | -8.7 | ||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -28.8 | -19.2 | -30.2 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -7.4 | -38.4 | -2.1 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -6.1 | -7.5 | -6.9 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -27.5 | -12.3 | -32.9 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -69.8 | -77.4 | -72.1 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -10.8 | -26.1 | -5.1 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 24.1 | 34.9 | 61 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 34.9 | 61 | 66.2 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 72.7 | 57 | 75.6 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -16.1 | -6.7 | -8.4 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 56.7 | 50.3 | 67.2 |
Gelir Tablosu Satırı
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 445.6 | 424.6 | 398.6 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 148.9 | 143.9 | 130 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 296.7 | 280.6 | 268.6 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -0.8 | 30.9 | 13.7 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 229.6 | 229.1 | 191.2 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 378.5 | 373.1 | 321.3 | ||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0.7 | 8.5 | 0.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 16.5 | 12.9 | 25.7 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 1.3 | -29.4 | -26.5 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -0.8 | 30.9 | 13.7 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 1.3 | -29.4 | -26.5 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 16.5 | 12.9 | 25.7 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 21.5 | 20.8 | 26.1 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 67.1 | 46.9 | 77.4 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 52.3 | 17.5 | 50.9 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 8.3 | 5.2 | 4.4 | ||||||||||||||||||||
income-statement-row.row.net-income | 0 | 18.5 | 12.3 | 46.5 |
Sıkça Sorulan Sorular
Nedir Medical Facilities Corporation (DR.TO) toplam varlıklar?
Medical Facilities Corporation (DR.TO) toplam varlıklar 354885000.000 şeklindedir.
İşletmenin yıllık geliri nedir?
Yıllık gelir N/A'dur.
Firma kâr marjı nedir?
Firma kar marjı 0.666'dir.
Şirket serbest nakit akışı nedir?
Serbest nakit akışı 1.082'dur.
İşletme net kar marjı nedir?
Net kâr marjı 0.053'dir.
Firma toplam geliri nedir?
Toplam gelir 0.151'dur.
Nedir Medical Facilities Corporation (DR.TO) net kar (net gelir)?
Net kar (net gelir) 18503000.000'dur.
Firmanın toplam borcu nedir?
Toplam borç 116809000.000'dir.
Faaliyet giderleri rakamı nedir?
İşletme giderleri 229573000.000'dır.
Şirket nakit rakamı nedir?
İşletme içi nakit 0.000'tir.